Replacing An Existing Paper-Based GMP Record System And Manual Process With An Electronic Monitoring System To Comply With FDA 21 CFR Part 11

With a more than 20-year reputation as a trusted source of innovative solutions in clinical diagnostics, Fujirebio Diagnostics, Inc.’s proven manufacturing process for the production of biomarkers has made it a global partner of choice among leading diagnostics companies around the world.  Being in the life sciences industry, Fujirebio adheres to a strict manufacturing process. The biomarkers produced by Fujirebio help physicians, lab professionals and patients better manage disease.